The Anglo-Swedish company is facing challenges in distributing its Govt-19 vaccine and working to modify existing drugs to fight the virus.
AstraZeneca announced this Friday (20) that its antibody therapy has achieved the key goal of preventing Govit-19, paving the way for the British pharmaceutical company to offer an alternative route to people with vulnerable systems. Immune systems.
The company claims that a cocktail of two types of antibodies, first discovered by the University of Vanderbilt University Medical Center in the United States, has reduced the risk of developing symptomatic Covid-19 by 77%.
Astrogeneca explained that more than 75% of participants had chronic problems, some associated with a weakened immune response to the vaccine.
The results bring relief to the drugmaker, who announced in June that a low-level testing, antibody cocktail, now known as AZD7442, provided no evidence that it protected people infected with the new corona virus.
The Anglo-Swedish company is facing challenges in distributing its Govt-19 vaccine and working to modify existing drugs to fight the virus.
“Music geek. Coffee lover. Devoted food scholar. Web buff. Passionate internet guru.”
More Stories
Elon Musk’s daughter is waiting to formalize the name change
“Brazilian” Russian spy identified while trying to start internship at International Criminal Court – Observer
More than 20 bodies have been mysteriously found in a nightclub in South Africa